Please login to the form below
research
This page shows the latest research news and features for those working in and with pharma, biotech and healthcare.
Opdivo improves survival in oesophageal cancer
BMS releases new data from its phase 3 CHECKMATE-648 study
Latest news
-
Keytruda shows significant and meaningfully improvement in kidney cancer
Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories said: “Since its first approval in renal cell carcinoma nearly two years ago, Keytruda ... This new data is the result of our
-
EMA again states that benefits of AZ vaccine outweigh risks
Drug regulator concludes that unusual blood clots are very rare
-
Alternatives to AZ vaccine should be offered to those under 30 in the UK
Blood clots are still seen as a very rare side effect to the AZ vaccine
-
J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
J&J’s deal with Cidara Therapeutics for new class of flu drugs is worth up to $780m
-
CanSinoBIO considers booster jab for COVID-19 vaccine
Chinese biotech company said the efficacy rate for the one-dose vaccine could decrease over time
More from news
Approximately 126 fully matching, plus 4,749 partially matching documents found.
Latest Intelligence
-
Unlock the power of data to realise strategic goals
It should be validated and, if necessary, completed through further research to fill in any gaps.
-
A new era for UK-Japanese scientific research relations
Most recently, Japanese firms have led research on plasma-based treatments for COVID-19. ... This has partly been driven by the perceived lack of availability of potential volunteers, and the cost associated with this research.
-
New thinking, bold action: building a better future for people living with severe diseases
Our presentations – including 15 scientific posters – demonstrated research that was informed by the latest science and guided by the needs of patients. ... In our mission to better serve all who live with severe diseases, we announced new research
-
Could the rare disease community teach pharma a lesson?
They get involved with patient organisations, from fundraising and events to advocacy for research funding and treatment access. ... Don’t skimp on thorough research or consumer testing if you want to ensure your message resonates.
-
The value of Patient Support Programmes
We know from our research that patients have ways of seeing and understanding their condition and treatment that are often at odds with the medical model.
More from intelligence
Approximately 31 fully matching, plus 746 partially matching documents found.
Latest appointments
-
Dan Carucci becomes global chief medical officer of McCann Health
Dan has deep global medical experience, a vast science research background and an incredibly impressive pedigree,” said John Cahill, global chief executive officer, McCann Health.
-
Genmab appoints Tahamtan Ahmadi as chief medical officer, head of experimental medicines
In his new role at Genmab, Ahmadi he will lead research, discovery, regulatory and medical activities.
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
Skinner joins the AMR Action Fund with extensive biomedical and investment funding experience, having spent decades in the biomedical research, venture and the pharmaceutical industries. ... for Biomedical Research.
-
Eli Lilly promotes Anat Ashkenazi to chief financial officer
Most recently, Ashkenazi served as senior vice president, controller and CFO of Lilly Research Laboratories. ... She has worked at Lilly for almost 20 years, having served in her most recent role at Lilly Research Laboratories since 2016.
-
Merck’s CEO Kenneth Frazier to retire after ten years in the role
Frazier is handing the reins over to current Merck CFO Robert Davis
More from appointments
Approximately 32 fully matching, plus 754 partially matching documents found.
Latest from PMHub
-
Live Webinar: Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
Fireside Chat with Jennifer Cox, Manager of Research Contracts at The Ottawa Hospital Research Institute. ... Manager, Research Contracts at Ottawa Hospital Research Institute (OHRI), will sit down with Natalie Yeadon for a thought-provoking
-
Why it’s in everyone’s interest the Women’s Health Strategy for England succeeds
It would be a huge leap forward if the Health Strategy for England could improve the representation of women in pharmaceutical research.
-
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell.
-
Feeling the pressure?
References. Digiday Market Research. Cited: [Accessed April 2021]. CIPR. State of the Profession Report, 2020.
-
MarketsResearch.biz
MarketsResearch.Biz is a single destination for all the industry, company and country reports. We have a leading market intelligence team which accredits and provides the reports of some of the top publishers in the field of the technology industry.
More from PMHub
Approximately 198 fully matching, plus 1,105 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Principal Medical Writer
-
Varies on experience
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
-
Account Management
-
Competitive Salary Offered
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- CureVac expands COVID-19 vaccine trial protocol to include variant specification
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Merck & Co, Ridgeback Biotherapeutics’ COVID-19 drug shows early promise
- Moderna launches COVID-19 vaccine booster study to address new variants
- Live Webinar: Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Opdivo improves survival in oesophageal cancer
- Keytruda shows significant and meaningfully improvement in kidney cancer
- Congress 2020 BC (before COVID-19)
- Shaping the Future of Medicine, Science, and Technology
- Live Webinar: Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
- How to tell your healthcare story.
- Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....
Quick links
Infographics
